1. Home
  2. TOMZ vs PHIO Comparison

TOMZ vs PHIO Comparison

Compare TOMZ & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.59

Market Cap

14.5M

Sector

Finance

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.20

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
PHIO
Founded
1979
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
14.6M
IPO Year
2009
2011

Fundamental Metrics

Financial Performance
Metric
TOMZ
PHIO
Price
$0.59
$1.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$3.50
$10.67
AVG Volume (30 Days)
217.6K
562.0K
Earning Date
05-07-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,738,842.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$68.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.23
N/A
52 Week Low
$0.54
$0.81
52 Week High
$1.20
$4.19

Technical Indicators

Market Signals
Indicator
TOMZ
PHIO
Relative Strength Index (RSI) 40.03 53.41
Support Level $0.54 $1.01
Resistance Level $0.81 $1.43
Average True Range (ATR) 0.05 0.08
MACD -0.00 0.01
Stochastic Oscillator 47.32 77.56

Price Performance

Historical Comparison
TOMZ
PHIO

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: